Brazil’s groundbreaking update to drug pricing regulations is shaking up the pharmaceutical landscape! Companies are now required to present stronger evidence showcasing their products’ effectiveness and cost-efficiency. This pivotal change could transform market dynamics and enhance access to vital medications throughout the country.
Eli Lilly’s recent launch of its weight-loss drug in India is set to transform the competitive landscape of the burgeoning market. With obesity rates rising, rivals are now poised to accelerate their efforts to capture a share of this lucrative opportunity.
Australia’s trade tensions with the Trump administration escalated over affordable medicines. The U.S. criticized Australia’s pharmaceutical pricing policies, arguing they undermined fair trade, while Australia defended its system aimed at ensuring low-cost access to essential drugs.
